Starget Pharma

Starget Pharma is an innovative clinical-stage biotechnology research company dedicated to developing a robust pipeline of radioligand therapy programs. Utilizing its proprietary Backbone Dynamics peptide platform, Starget Pharma leverages cutting-edge backbone cyclic innovations and in-silico AI. This approach allows for the rapid design of highly specific Smart Targeted Radioligands (STRs) engineered to deliver focused radiation.

Starget Pharma is committed to revolutionizing the imaging and treatment of hard-to-treat cancers through precision-targeted therapies. The company’s focus on innovation and advanced technologies positions it as a key player in the future of cancer treatment. Starget Pharma's dedication to research and development promises significant advancements in the field.

The team at Starget Pharma is constantly working to refine its technologies and expand its pipeline, with more exciting developments on the horizon. We invite the management of Starget Pharma to create a customized and exclusive company showcase and product listing on our platform to further highlight their achievements and advancements in biotechnology.